Presumptive antemortem diagnosis of degenerative myelopathy (DM) in German Shepherd Dogs (GSDs) rests on three pillars: compatible clinical signs, SOD1 homozygosity on genetic testing, and exclusion of other thoracolumbar myelopathies by spinal MRI and cerebrospinal fluid (CSF) analysis. Definitive diagnosis requires postmortem histopathology of the spinal cord. Journal of Vete…+2
The clinical presentation is characteristic but not pathognomonic. DM begins as insidious, asymmetric general proprioceptive ataxia and upper motor neuron spastic paraparesis of the pelvic limbs, progressing to lower motor neuron paraplegia, then flaccid tetraplegia, and ultimately respiratory failure if euthanasia is not elected. MSD Vet Manuals+2 In GSDs allowed to progress without euthanasia, death from respiratory failure occurs approximately 3 years after disease onset. BMC Veterinary…
Genetic testing for the SOD1:c.118G>A missense mutation is the cornerstone of the diagnostic workup. The mutation is inherited in an autosomal recessive pattern with incomplete penetrance; homozygosity for the A allele (A/A genotype) confers high risk for clinical DM, while heterozygotes (G/A) rarely develop clinical signs. MSD Vet Manuals+1 In GSD populations, the A allele frequency has been reported at 0.220 in Japan, 0.23 in Uruguay, 0.15 in Paraguay, and 0.121 in Brazil (where no A/A homozygotes were identified in the sampled population). Animals+2 Among A/A dogs older than 10 years, clinical progression rate reaches 100% in both Japanese and South American GSD populations. Animals+1 A second mutation, SOD1:c.52A>T, has been identified only in Bernese Mountain Dogs and is not relevant to GSDs. PLoS ONE+1
The majority of neurologists require genetic testing for the SOD1 mutation to support a presumptive DM diagnosis; 82 of 189 neurologist respondents also require spinal MRI. Journal of Vete… Spinal MRI is essential to exclude structural differentials — intervertebral disc extrusion, spinal neoplasia, and other compressive myelopathies — because DM lesions are not visible on conventional MRI sequences and CSF changes are nonspecific. Journal of Vete… In dogs presenting with thoracolumbar signs and no MRI lesion, further workup including CSF cytology, infectious disease testing, and SOD1 genotyping is indicated; in one series, 5 of 14 dogs with negative thoracolumbar MRI tested positive for DM risk genotype. Journal of the… Diffusion tensor imaging (DTI) detects microstructural white matter changes not visible on conventional sequences and is an emerging noninvasive biomarker, though it is not yet standard of care. Journal of Vete…+1
Toenail wear pattern is a useful low-cost clinical clue — the 2023 AAHA Senior Care Guidelines specifically recommend evaluating toenail wear as part of the neurologic assessment in senior dogs, alongside SOD1 testing and MRI consideration. AAHA Clinical G…
There is no medical therapy shown to alter DM progression. Epsilon-aminocaproic acid, N-acetylcysteine, and supplementation with Vitamins C and E have been investigated and found to provide no evidence of benefit. Journal of Vete…
Physical rehabilitation is the only intervention that slows progression and prolongs quality of life. Rehabilitation goals are preservation or improvement of strength (reported by 78/79 rehabilitation respondents) and coordination (77/79). Journal of Vete…+1 The most commonly used modalities are at-home exercises (75/79 respondents), strength-building exercises (65/79), underwater treadmill (64/79), and gait training (55/79), targeting maintenance of strength (58/79), coordination (56/79), and muscle mass (56/79), as well as improvement of overall wellbeing (54/79). Journal of Vete… Exercise is recommended by 187/190 neurologist respondents and formal physical rehabilitation by 184/190. Journal of Vete…
Euthanasia timing differs between specialist groups. Neurologist respondents report that owners most commonly elect euthanasia when dogs become nonambulatory paraparetic, while rehabilitation respondents report euthanasia is typically elected when paraplegia and incontinence develop. Journal of Vete…
Recheck examinations are performed by over 50% (102/190) of neurology respondents to monitor progression, and continued care after diagnosis is frequently managed by rehabilitation professionals or primary veterinarians rather than neurologists. Journal of Vete…
| Step | What to Do | Key Finding / Threshold | Caveat |
|---|---|---|---|
| Genetic testing | SOD1:c.118G>A genotyping | A/A = high risk; 100% clinical progression rate in A/A dogs >10 yr Animals+1 | Incomplete penetrance; not all A/A dogs develop signs |
| Spinal MRI | Rule out compressive/structural myelopathy | DM lesions invisible on conventional sequences Journal of Vete… | DTI detects microstructural changes but not standard of care Journal of Vete…+1 |
| CSF analysis | Rule out inflammatory/infectious myelopathy | Changes nonspecific for DM Journal of Vete… | Required for diagnosis of exclusion |
| Medical therapy | None proven effective | EACA, NAC, Vitamins C/E — no benefit Journal of Vete… | — |
| Rehabilitation | Underwater treadmill, gait training, strength exercises | Only intervention slowing progression Veterinary Clin… | Goals: strength, coordination, muscle mass, wellbeing Journal of Vete… |
Would you like guidance on structuring a rehabilitation protocol — including exercise frequency, intensity progression, and when to transition from ambulatory to non-ambulatory management?